BioLASCO Taiwan Co. Ltd.(TW:6662)
NT$28.400.00 (0.00%)
TW:6662
BioLASCO Taiwan Co. Ltd. financials statements
NT$28.40
At close:0.00 (0.00%)
BioLASCO Taiwan Co. Ltd. (6662) Ratios
BioLASCO Taiwan Co. Ltd. Ratios
TW:6662's free cash flow for Q2 2026 was NT$14.96M. For the 2026 fiscal year, TW:6662's free cash flow was decreased by NT$-2.11M and operating cash flow was NT$17.07M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.93 | 3.66 | 4.83 | 5.09 | 5.93 |
| Quick Ratio | 3.37 | 3.12 | 4.25 | 4.72 | 5.57 |
| Cash Ratio | 1.50 | 1.57 | 2.38 | 2.99 | 4.01 |
| Solvency Ratio | 0.40 | 0.34 | 0.54 | 0.45 | 0.48 |
| Operating Cash Flow Ratio | 0.91 | 0.83 | 0.49 | 0.79 | 1.41 |
| Short-Term Operating Cash Flow Coverage | 4.03 | 5.05 | 5.52 | 8.38 | 13.28 |
| Net Current Asset Value | NT$ 76.25M | NT$ 85.99M | NT$ 177.86M | NT$ 172.28M | NT$ 183.17M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.17 | 0.10 | 0.12 | 0.12 |
| Debt-to-Equity Ratio | 0.20 | 0.24 | 0.13 | 0.15 | 0.15 |
| Debt-to-Capital Ratio | 0.17 | 0.19 | 0.11 | 0.13 | 0.13 |
| Long-Term Debt-to-Capital Ratio | 0.15 | 0.17 | 0.10 | 0.11 | 0.12 |
| Financial Leverage Ratio | 1.29 | 1.36 | 1.24 | 1.25 | 1.25 |
| Debt Service Coverage Ratio | 3.71 | 4.36 | 9.29 | 7.58 | 9.03 |
| Interest Coverage Ratio | 23.64 | 31.74 | 39.17 | 49.98 | 65.40 |
| Debt to Market Cap | 0.12 | 0.12 | 0.07 | 0.08 | 0.09 |
| Interest Debt Per Share | 3.73 | 4.25 | 2.32 | 2.62 | 2.74 |
| Net Debt to EBITDA | 0.22 | 0.00 | -1.15 | -1.72 | -1.96 |
| Profitability Margins | |||||
| Gross Profit Margin | 38.69% | 39.24% | 39.42% | 44.29% | 46.18% |
| EBIT Margin | 18.29% | 19.38% | 23.91% | 20.88% | 25.19% |
| EBITDA Margin | 22.68% | 23.13% | 27.90% | 25.22% | 29.59% |
| Operating Profit Margin | 18.29% | 19.04% | 19.18% | 22.98% | 25.20% |
| Pretax Profit Margin | 18.87% | 18.78% | 23.42% | 22.52% | 24.80% |
| Net Profit Margin | 16.15% | 15.05% | 18.79% | 17.94% | 19.84% |
| Continuous Operations Profit Margin | 16.15% | 15.05% | 18.79% | 15.95% | 18.65% |
| Net Income Per EBT | 85.60% | 80.17% | 80.24% | 79.62% | 80.00% |
| EBT Per EBIT | 103.16% | 98.58% | 122.12% | 98.00% | 98.41% |
| Return on Assets (ROA) | 7.16% | 7.19% | 8.68% | 7.43% | 7.86% |
| Return on Equity (ROE) | 9.27% | 9.80% | 10.79% | 9.31% | 9.81% |
| Return on Capital Employed (ROCE) | 8.92% | 10.23% | 9.89% | 10.56% | 10.94% |
| Return on Invested Capital (ROIC) | 7.45% | 8.02% | 7.84% | 8.29% | 8.65% |
| Return on Tangible Assets | 7.16% | 7.19% | 8.68% | 7.43% | 7.86% |
| Earnings Yield | 5.34% | 5.19% | 5.83% | 5.53% | 5.79% |
| Efficiency Ratios | |||||
| Receivables Turnover | 7.08 | 6.58 | 5.36 | 7.52 | 7.46 |
| Payables Turnover | 30.67 | 9.06 | 29.21 | 15.58 | 21.59 |
| Inventory Turnover | 5.34 | 4.84 | 4.68 | 6.30 | 6.83 |
| Fixed Asset Turnover | 1.05 | 1.23 | 1.39 | 1.20 | 1.14 |
| Asset Turnover | 0.44 | 0.48 | 0.46 | 0.41 | 0.40 |
| Working Capital Turnover Ratio | 1.55 | 1.42 | 1.15 | 0.99 | 0.89 |
| Cash Conversion Cycle | 107.92 | 90.72 | 133.69 | 83.00 | 85.48 |
| Days of Sales Outstanding | 51.53 | 55.50 | 68.12 | 48.51 | 48.93 |
| Days of Inventory Outstanding | 68.29 | 75.48 | 78.07 | 57.92 | 53.46 |
| Days of Payables Outstanding | 11.90 | 40.27 | 12.50 | 23.43 | 16.91 |
| Operating Cycle | 119.82 | 130.98 | 146.19 | 106.43 | 102.39 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.90 | 2.22 | 1.15 | 1.74 | 2.77 |
| Free Cash Flow Per Share | 1.06 | 0.04 | 1.09 | 1.58 | 2.60 |
| Dividend Paid and CapEx Coverage Ratio | 0.81 | 0.58 | 0.74 | 0.99 | 1.27 |
| Capital Expenditure Coverage Ratio | 2.25 | 1.02 | 18.07 | 10.46 | 16.26 |
| Operating Cash Flow Coverage Ratio | 0.52 | 0.53 | 0.51 | 0.68 | 1.02 |
| Operating Cash Flow to Sales Ratio | 0.19 | 0.19 | 0.11 | 0.19 | 0.31 |
| Free Cash Flow Yield | 3.41% | 0.11% | 3.26% | 5.29% | 8.53% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 18.67 | 19.24 | 17.16 | 18.09 | 17.30 |
| Price-to-Sales (P/S) Ratio | 3.02 | 2.90 | 3.23 | 3.24 | 3.43 |
| Price-to-Book (P/B) Ratio | 1.73 | 1.89 | 1.85 | 1.68 | 1.69 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 29.34 | 910.59 | 30.68 | 18.92 | 11.73 |
| Price-to-Operating Cash Flow Ratio | 16.30 | 14.91 | 28.98 | 17.11 | 11.01 |
| Price-to-Earnings Growth (PEG) Ratio | -5.35 | -1.70 | 0.98 | -2.89 | -0.61 |
| Enterprise Value Multiple | 13.54 | 12.54 | 10.41 | 11.13 | 9.62 |
| Enterprise Value | 806.85M | 847.95M | 769.07M | 661.96M | 647.89M |
| EV to EBITDA | 13.54 | 12.54 | 10.41 | 11.13 | 9.62 |
| EV to Sales | 3.07 | 2.90 | 2.91 | 2.81 | 2.85 |
| EV to Free Cash Flow | 29.82 | 910.79 | 27.64 | 16.38 | 9.74 |
| EV to Operating Cash Flow | 16.56 | 14.91 | 26.11 | 14.81 | 9.15 |
| Tangible Book Value Per Share | 17.86 | 17.53 | 17.97 | 17.73 | 17.97 |
| Shareholders’ Equity Per Share | 17.87 | 17.55 | 17.99 | 17.75 | 17.97 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.20 | 0.20 | 0.20 | 0.20 |
| Revenue Per Share | 10.26 | 11.42 | 10.32 | 9.21 | 8.89 |
| Net Income Per Share | 1.66 | 1.72 | 1.94 | 1.65 | 1.76 |
| Tax Burden | 0.86 | 0.80 | 0.80 | 0.80 | 0.80 |
| Interest Burden | 1.03 | 0.97 | 0.98 | 1.08 | 0.98 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.20 | 0.20 | 0.20 | 0.23 | 0.22 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.98 | 1.04 | 0.59 | 0.84 | 1.26 |
Currency in TWD
